Trial Outcomes & Findings for A Rehabilitation Tool to Determine Patient's Stay in Hospital After Joint Replacement (NCT NCT03776357)

NCT ID: NCT03776357

Last Updated: 2022-06-30

Results Overview

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

9 participants

Primary outcome timeframe

Up to 2 days

Results posted on

2022-06-30

Participant Flow

Participant milestones

Participant milestones
Measure
Experimental
Participants utilize FDA cleared Virtual Exercise Rehabilitation Assistant (VERA™) platform during pre-operative visit to obtain functional outcome scores.
Overall Study
STARTED
9
Overall Study
COMPLETED
6
Overall Study
NOT COMPLETED
3

Reasons for withdrawal

Reasons for withdrawal
Measure
Experimental
Participants utilize FDA cleared Virtual Exercise Rehabilitation Assistant (VERA™) platform during pre-operative visit to obtain functional outcome scores.
Overall Study
Lost to Follow-up
3

Baseline Characteristics

A Rehabilitation Tool to Determine Patient's Stay in Hospital After Joint Replacement

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Experimental
n=9 Participants
Participants utilize the VERA platform during pre-operative visit to obtain functional outcome scores.
Age, Categorical
<=18 years
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
9 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
Sex: Female, Male
Female
5 Participants
n=5 Participants
Sex: Female, Male
Male
4 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
7 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
1 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
3 Participants
n=5 Participants
Race (NIH/OMB)
White
4 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Region of Enrollment
United States
9 Participants
n=5 Participants
Gait aide use
Nothing
9 Participants
n=5 Participants
Gait aide use
Cane
0 Participants
n=5 Participants
Gait aide use
crutch
0 Participants
n=5 Participants
Gait aide use
walker
0 Participants
n=5 Participants
Range of motion ( maximum degrees)
Extension
0.6 degrees
STANDARD_DEVIATION 1.7 • n=5 Participants
Range of motion ( maximum degrees)
Flexion
117.8 degrees
STANDARD_DEVIATION 5.7 • n=5 Participants

PRIMARY outcome

Timeframe: Up to 2 days

Outcome measures

Outcome measures
Measure
Experimental
n=9 Participants
Participants utilize the VERA platform during pre-operative visit to obtain functional outcome scores.
Length of Stay in Hospital Through Discharge
2 days
Interval 2.0 to 2.0

SECONDARY outcome

Timeframe: 3 months post operative visit

The gait aide use ranges in the order of decreasing performance as Nothing \> Cane \> crutch \> walker.

Outcome measures

Outcome measures
Measure
Experimental
n=9 Participants
Participants utilize the VERA platform during pre-operative visit to obtain functional outcome scores.
Number of Participants Requiring Gait Aid Use
None ( no gait aide)
9 Participants
Number of Participants Requiring Gait Aid Use
Cane
0 Participants
Number of Participants Requiring Gait Aid Use
Crutch
0 Participants
Number of Participants Requiring Gait Aid Use
Walker
0 Participants

SECONDARY outcome

Timeframe: 3 months post operative visit

To assess the effectiveness of the device by calculating knee society score (KSS) after surgery. The scale ranges from 0-100 with grading as Score 80-100 - Excellent Score 70-79 - Good Score 60-69 - Fair Score below 60 - Poor

Outcome measures

Outcome measures
Measure
Experimental
n=9 Participants
Participants utilize the VERA platform during pre-operative visit to obtain functional outcome scores.
Knee Society Score (KSS)
Excellent (80-100)
6 Participants
Knee Society Score (KSS)
Good (70-79)
0 Participants
Knee Society Score (KSS)
Fair (60-69)
2 Participants
Knee Society Score (KSS)
Poor ( below 60)
1 Participants

SECONDARY outcome

Timeframe: 3 months post operative visit

To assess the effectiveness of the device by calculating range of motion (maximum degrees)

Outcome measures

Outcome measures
Measure
Experimental
n=9 Participants
Participants utilize the VERA platform during pre-operative visit to obtain functional outcome scores.
Knee Range of Motion
extension
1.1 degrees
Standard Deviation 2.2
Knee Range of Motion
flexion
107.8 degrees
Standard Deviation 17.5

Adverse Events

Experimental

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Derek Amanatullah, MD, PhD

Stanford University

Phone: 650-723-2257

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place